D
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Donald M. Mock's research has focused on the study of antibodies and their role in red blood cell survival following transfusions. His recent publications investigate the impact of biotin-labeled red blood cells and the broader implications of biotin in biological processes. With a career marked by significant scholarly output, Mock holds an h-index of 41 and has authored over 330 publications, garnering more than 5,400 citations. He is recognized as a highly cited researcher. His collaborative network includes Svetlana V. Kyosseva from the University of Arkansas for Medical Sciences, with whom he shares multiple publications.
Metrics
- h-index: 41
- Publications: 331
- Citations: 5,497
Selected Publications
-
Antibodies against biotin‐labeled red blood cells can shorten <scp>posttransfusion</scp> survival (2022)
-
Biotin (2022)
Collaboration Network
Top Collaborators
Luis Fontana
Instituto de Investigación Biosanitaria de Granada (ES)
1 shared publication
- Biotin
Sean R. Stowell
Emory University (US)
1 shared publication
- Antibodies against biotin‐labeled red blood cells can shorten <scp>posttransfusion</scp> survival
Robert S. Franco
University of Cincinnati Medical Center (US)
1 shared publication
- Antibodies against biotin‐labeled red blood cells can shorten <scp>posttransfusion</scp> survival
Svetlana V. Kyosseva
University of Arkansas for Medical Sciences
1 shared publication
In database
- Antibodies against biotin‐labeled red blood cells can shorten <scp>posttransfusion</scp> survival
Demet Nalbant
University of Iowa (US)
1 shared publication
- Antibodies against biotin‐labeled red blood cells can shorten <scp>posttransfusion</scp> survival
Robert L. Schmidt
University of Iowa (US)
1 shared publication
- Antibodies against biotin‐labeled red blood cells can shorten <scp>posttransfusion</scp> survival
Gretchen A. Cress
University of Iowa (US)
1 shared publication
- Antibodies against biotin‐labeled red blood cells can shorten <scp>posttransfusion</scp> survival
Ronald G. Strauss
University of Iowa (US)
1 shared publication
- Antibodies against biotin‐labeled red blood cells can shorten <scp>posttransfusion</scp> survival
José A. Cancelas
University of Cincinnati (US)
1 shared publication
- Antibodies against biotin‐labeled red blood cells can shorten <scp>posttransfusion</scp> survival
Melissa von Goetz
Cerus (United States) (US)
1 shared publication
- Antibodies against biotin‐labeled red blood cells can shorten <scp>posttransfusion</scp> survival
Anne North
Cerus (United States) (US)
1 shared publication
- Antibodies against biotin‐labeled red blood cells can shorten <scp>posttransfusion</scp> survival
John A. Widness
University of Iowa (US)
1 shared publication
- Antibodies against biotin‐labeled red blood cells can shorten <scp>posttransfusion</scp> survival
Similar Researchers
Based on overlapping research topics
Ginell Post
University of Arkansas for Medical Sciences
Hematopoietic Stem Cell Transplantation
Immune Response and Inflammation
Molecular Biology Techniques and Applications
Charles E. Hay
University of Arkansas for Medical Sciences
Monoclonal and Polyclonal Antibodies Research
Immune Response and Inflammation
Molecular Biology Techniques and Applications
Jinho Bang
University of Arkansas at Fayetteville
Monoclonal and Polyclonal Antibodies Research
Molecular Biology Techniques and Applications
Ginell R. Post
University of Arkansas for Medical Sciences
Hematopoietic Stem Cell Transplantation
Immune Response and Inflammation
Molecular Biology Techniques and Applications
Jeanette M. Ramos
University of Arkansas for Medical Sciences
Hematopoietic Stem Cell Transplantation
Immune Response and Inflammation
Molecular Biology Techniques and Applications
Prashant Sadaram
University of Arkansas for Medical Sciences
Hematopoietic Stem Cell Transplantation
Immune Response and Inflammation